Fentanyl CRI

Short-acting µ-opioid agonist, roughly 80–100× more potent than morphine on a mg-for-mg basis. Onset is within 1–2 minutes IV and the effect dissipates within 20–30 minutes after a CRI is stopped, which is what makes it useful for ICU patients who need their analgesia interrupted for neurologic reassessment. Provides analgesia, sedation, and dose-related respiratory depression; bradycardia is common but vasodilation is not. DEA Schedule II controlled substance.

Open calculator →

Clinical background

Fentanyl is the workhorse opioid for hospitalized small-animal patients in pain. It is roughly 80–100 times more potent than morphine, has a short duration of action that allows quick titration, and has predictable cardiopulmonary effects when used carefully. The CRI form is particularly useful in critically ill patients because the infusion can be paused for 15–30 minutes to assess neurologic status without losing analgesia for hours.

Pharmacology

Mu-opioid agonist. Activation of central mu receptors mediates analgesia, euphoria (or dysphoria, depending on the patient), respiratory depression, miosis, and the hypothermic effects characteristic of opioids. Fentanyl is highly lipophilic, which gives it rapid CNS penetration, but it is also extensively redistributed into peripheral tissues, the clinical duration after a single bolus is shorter than the elimination half-life would predict, because the drug redistributes out of the CNS before it is eliminated. Steady-state during a CRI takes longer to reach (≈30–60 min); when the CRI is stopped, the offset is correspondingly longer than after a single bolus.

DEA Schedule II (C-II) controlled substance. Standard veterinary practice for handling, recording, and disposal applies.

Indications

Primary use cases:

• Adjunctive postoperative pain control
• Severe medical pain, pancreatitis, cancer, peritonitis, aortic thromboembolism, trauma
• Perioperative MAC sparing during inhalant anesthesia in dogs (reduces inhalant requirements; particularly useful in patients with compromised cardiac function)
• ICU sedation as part of a balanced protocol with other agents

Cats can receive fentanyl CRI for analgesia, but two species-specific points are important:

1. Fentanyl does not provide a meaningful MAC-sparing effect in cats, the inhalant requirement is essentially unchanged. Use fentanyl in cats for analgesia, not for inhalant reduction.
2. Opioid-induced mydriasis is common in cats and pronounced enough to interfere with environmental orientation. Approach the cat slowly and keep the recovery area dimly lit.

Dosing

• Dogs, perioperative analgesia: 2–10 µg/kg/hr CRI (after a 2–10 µg/kg IV loading dose)
• Dogs, adjunct anesthesia / severe pain with controlled ventilation: 5–20, up to 40 µg/kg/hr
• Cats, perioperative analgesia: 5 µg/kg/hr CRI
• Cats, adjunct anesthesia / severe pain: 5–20 µg/kg/hr

The default in this calculator is 5 µg/kg/hr, which sits comfortably in the standard range for both species. Doses above 10 µg/kg/hr increase the risk of clinically significant respiratory depression, those higher rates assume controlled ventilation or active airway management.

A loading dose is usually given with the first hour of CRI: 2–5 µg/kg IV slowly for routine postoperative pain, up to 10 µg/kg IV for severe acute pain. Faster bolus injection causes more cardiovascular effect (bradycardia, occasionally hypotension), always give slowly.

Administration

Fentanyl can be administered undiluted from the 50 µg/mL stock vial for most patients, or diluted into 5% dextrose, 0.9% sodium chloride, lactated Ringer’s, Plasma-Lyte, or 6% hetastarch for very small patients where the undiluted pump rate would be too low for accurate delivery.

Once a vial is punctured, use immediately and discard any unused solution. Fentanyl is compatible in the same line with most common anesthetic and analgesic drugs (lidocaine, ketamine, midazolam, morphine, hydromorphone) and with most crystalloids.

Drug interactions

• Other opioids and sedatives (benzodiazepines, α₂ agonists, acepromazine, propofol, inhalants), additive CNS and respiratory depression. Combinations are common and useful, but doses of each should be reduced.
• Monoamine oxidase inhibitors: risk of serotonin syndrome; avoid concurrent use.
• CYP3A4 inhibitors and inducers can alter fentanyl exposure but most aren’t routinely encountered in veterinary practice.

Adverse effects

The two effects to watch most closely:

• Respiratory depression: bradypnea, hypercapnia, and CNS depression are dose-related and additive with other anesthetic drugs. Have naloxone immediately available and a plan for assisted ventilation if needed.
• Bradycardia: vagally mediated, usually responds to anticholinergics if hemodynamically significant. Reducing the infusion rate is often sufficient.

Other reported effects:

• Mild hypotension, particularly with rapid bolus administration
• Dysphoria, more common in cats and in older dogs; manifests as restlessness, panting, or vocalization despite adequate analgesia. Reducing the rate or rotating to a different opioid usually resolves it.
• Hyperalgesia or opioid tolerance with sustained high-dose CRI (>24–48 hours)
• Decreased GI motility, relevant in postoperative ileus risk and in patients with compromised GI function
• Urine retention
• Hyperthermia in cats, particularly at higher doses
• Pruritus, uncommon

Monitoring

• Respiratory rate and effort, ETCO₂ where available, SpO₂
• Heart rate and rhythm, bradycardia is dose-limiting more often than hypotension
• Sedation level, graded scale or simple narrative every 1–2 hours
• Body temperature in cats
• Patient comfort using a validated pain scale (Glasgow CMPS-SF for dogs; Feline Grimace Scale or Glasgow CMPS-Feline for cats)

Fentanyl CRI should always be paired with a plan for breakthrough pain (an IV bolus protocol) and a plan for transition to an oral or longer-acting parenteral analgesic before discontinuation.

Weaning and discontinuation

Patients on a fentanyl CRI for less than 12–24 hours can usually have the rate halved every 30–60 minutes and then stopped. Patients on sustained high-dose CRIs may show signs of tolerance and benefit from a slower taper or rotation to a different opioid (methadone, hydromorphone) before transitioning off entirely.

If respiratory depression becomes a concern, naloxone reverses fentanyl effects rapidly. Use small titrated doses (0.04 mg/kg IV diluted to 1 mL, given in 0.1 mL increments), full reversal causes immediate, severe pain and should be reserved for true respiratory emergencies. After naloxone reversal, observe for re-narcotization as the naloxone wears off; the half-life of naloxone is shorter than that of fentanyl after a CRI.

Sources

• Plumb’s Veterinary Drugs, fentanyl monograph (current edition).